The addition of omeprazole to ondansetron for treating chemotherapy-induced nausea and vomiting in pediatric cancer patients

• Główni autorzy: Perjuangan Dapot Hamonangan Simbolon (Autor), Selvi Nafianti (Autor), Pertin Sianturi (Autor), Bidasari Lubis (Autor), Aznan Lelo (Autor)
• Format: Książka
• Wydane: Indonesian Pediatric Society Publishing House, 2018-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background Chemotherapy-induced nausea and vomiting are some of the most disturbing side effects in pediatric cancer patients. The standard recommendation is the use of 5-hydroxytryptamine 3 receptor antagonist, such as ondansetron, to treat these symptoms. Despite this treatment, more than 50% of p...